These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37140947)

  • 1. Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD.
    Pappe E; Hammerich R; Saccomanno J; Sgarbossa T; Pohrt A; Schmidt B; Grah C; Eisenmann S; Holland A; Eggeling S; Stanzel F; Witzenrath M; Hübner RH
    Chronic Obstr Pulm Dis; 2023 Jul; 10(3):211-223. PubMed ID: 37140947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.
    Halpin DMG; Criner GJ; Papi A; Singh D; Anzueto A; Martinez FJ; Agusti AA; Vogelmeier CF
    Am J Respir Crit Care Med; 2021 Jan; 203(1):24-36. PubMed ID: 33146552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 Pandemic on the Exacerbation Rates in COPD Patients in Southern India - A Potential Role for Community Mitigations Measures.
    Acharya VK; Sharma DK; Kamath SK; Shreenivasa A; Unnikrishnan B; Holla R; Gautham M; Rathi P; Mendonca J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1909-1917. PubMed ID: 37662487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic.
    Pleguezuelos E; Del Carmen A; Moreno E; Ortega P; Vila X; Ovejero L; Serra-Prat M; Palomera E; Garnacho-Castaño MV; Loeb E; Farago G; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2621-2627. PubMed ID: 33122900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales.
    Alsallakh MA; Sivakumaran S; Kennedy S; Vasileiou E; Lyons RA; Robertson C; Sheikh A; Davies GA;
    BMC Med; 2021 May; 19(1):124. PubMed ID: 33993870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET.
    Kahnert K; Lutter JI; Welte T; Alter P; Behr J; Herth F; Kauczor HU; Söhler S; Pfeifer M; Watz H; Vogelmeier CF; Bals R; Jörres RA; Trudzinski FC
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34430659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections.
    So JY; O'Hara NN; Kenaa B; Williams JG; deBorja CL; Slejko JF; Zafari Z; Sokolow M; Zimand P; Deming M; Marx J; Pollak AN; Reed RM
    Am J Med; 2021 Oct; 134(10):1252-1259.e3. PubMed ID: 34126098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 and lockdown on COPD admissions to Christchurch Hospital, New Zealand 2020-2021: a combined quantitative and qualitative study.
    Zhang X; Wilkinson A; Storer M; Epton MJ
    Intern Med J; 2023 Oct; 53(10):1768-1775. PubMed ID: 37548338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
    Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital Admission Rates in Patients with COPD Throughout the COVID-19 Pandemic.
    Andreen N; Westin J; Vanfleteren LEGW
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1763-1772. PubMed ID: 37608833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in ventilation and perfusion following lower lobe endoscopic lung volume reduction (ELVR) with endobronchial valves in severe COPD.
    Yang L; Hsu K; Williamson JP; Peters MJ; Ho-Shon K; Ing AJ
    Clin Respir J; 2019 Jul; 13(7):453-459. PubMed ID: 31006169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological airway colonization in COPD patients with severe emphysema undergoing endoscopic lung volume reduction.
    Trudzinski FC; Seiler F; Wilkens H; Metz C; Kamp A; Bals R; Gärtner B; Lepper PM; Becker SL
    Int J Chron Obstruct Pulmon Dis; 2018; 13():29-35. PubMed ID: 29296080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patients.
    Brock JM; Böhmker F; Schuster PU; Eberhardt R; Gompelmann D; Kontogianni K; Dittrich S; Benjamin N; Herth F
    Respir Med; 2023 Nov; 218():107399. PubMed ID: 37673413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Esterman AJ; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012347. PubMed ID: 30838649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
    Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.